Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.


Intellectual Property and Its Discontents
Washington Times, 10-14-04

This article argues that recent efforts to weaken intellectual property protections for drugs used heavily in the Third World, like those fighting HIV/AIDS, are wrongheaded. He contends that strong intellectual property rights spur innovation which leads the wide dissemination of new discoveries.

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000